HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elimian, A. Articles by Quirk, J. G. Search for Related Content PubMed PubMed Citation Articles by Elimian, A. Articles by Quirk, J. G. Related Collections General obstetrics Preterm labor Related Article

Antenatal Betamethasone Compared With Dexamethasone (Betacode Trial)

A Randomized Controlled Trial

From the ¹Department of Obstetrics, Gynecology and Reproductive Medicine and ²Department of Pediatrics, Stony Brook University, Stony Brook, New York.

OBJECTIVE: To compare betamethasone with dexamethasone in terms of effectiveness in reducing perinatal morbidities and mortality among preterm infants.

METHODS: We enrolled 299 women at risk for preterm delivery in a double-blind, placebo-controlled, randomized trial of antenatal betamethasone compared with dexamethasone at Stony Brook University Hospital from August 2002 through July 2004. We excluded women with clinical chorioamnionitis, fetal structural and chromosomal abnormalities, prior antenatal steroid exposure, and steroid use for other indications. Statistical analysis was performed in accordance of the intention-to-treat principle.

RESULTS: There were no significant differences between the groups with regard to baseline characteristics. The rate of respiratory distress syndrome, need for vasopressor therapy, necrotizing enterocolitis, retinopathy of prematurity, patent ductus arteriosus, neonatal sepsis, and neonatal mortality were not significant different between the groups. However, the rates of intraventricular hemorrhage (6 of 105 [5.7%] compared with 17 of 100 [17.0%], relative risk [RR] 2.97, 95% confidence interval [CI] 1.22–7.24, P=.02) and any brain lesion (7 of 105 [6.7%] compared with 18 of 100 [18.0%], RR 2.7, 95% CI 1.18–6.19, P=.02) were significantly lower in neonates exposed to dexamethasone compared with betamethasone. The absolute risk reduction in the rate of intraventricular hemorrhage was 11.3 % ( 95% CI 2.7–11.9%), and the number needed to treat was 9 (95% CI 5–37) in favor of dexamethasone.

CONCLUSION: Betamethasone and dexamethasone are comparable in reducing the rate of most major neonatal morbidities and mortality in preterm neonates. However, dexamethasone seems to be more effective in reducing the rate of intraventricular hemorrhage compared with betamethasone.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00418353

LEVEL OF EVIDENCE: I

Related Article

Betamethasone Compared With Dexamethasone for Preterm Birth: A Call for Trials

Kellie E. Murphy
Obstet. Gynecol. 2007 110: 7-9. [Full Text] [PDF]

This article has been cited by other articles:

				W. A. Campbell Antenatal Betamethasone Compared With Dexamethasone (Betacode Trial): A Randomized Controlled Trial Obstet. Gynecol., October 1, 2007; 110(4): 930 - 930. [Full Text] [PDF]

				R. C. Wallach Antenatal Betamethasone Compared With Dexamethasone (Betacode Trial): A Randomized Controlled Trial Obstet. Gynecol., October 1, 2007; 110(4): 930 - 930. [Full Text] [PDF]

				D. M. Strickland Antenatal Betamethasone Compared With Dexamethasone (Betacode Trial): A Randomized Controlled Trial Obstet. Gynecol., October 1, 2007; 110(4): 930 - 930. [Full Text] [PDF]

				K. E. Murphy Betamethasone Compared With Dexamethasone for Preterm Birth: A Call for Trials Obstet. Gynecol., July 1, 2007; 110(1): 7 - 9. [Full Text] [PDF]